Modulators of Ca2+ exchangers, blockers of aberrant gliotransmission, or interventions aimed at restoring buffering proteins like S100β could provide new treatment strategies for epilepsy, neurodegeneration, and neurodevelopmental disorders [6,33,53,112]. The gene discussed is S100B; the disease is epilepsy.